Healthcare security reports

Biogen Switzerland AG operates as a leading biotechnology company focused on pioneering scientific research and innovation in complex and severe diseases, particularly in neurology, neuropsychiatry, immunology, and rare diseases. The website reflects a strong market position with a comprehensive product portfolio and a clear commitment to improving health outcomes. The digital infrastructure is built on Adobe Experience Manager, leveraging modern web technologies including Cookiebot for privacy compliance and Google Analytics for user insights. The site is well-optimized for mobile and accessibility, with consistent branding and professional content presentation. Security posture is solid with HTTPS enforcement and secure cookie practices, though explicit security policies and incident response contacts are not publicly disclosed. Overall, the website demonstrates a mature digital presence aligned with corporate standards and regulatory compliance.

Biogen Sweden AB operates a professional and comprehensive website focused on biotechnology and healthcare, specifically targeting neurological and rare diseases. The company is positioned as a leading global biotechnology firm with a strong presence in Sweden, offering innovative treatments and scientific advancements. The website is well-structured, professionally designed, and provides detailed information about the company's mission, disease areas, career opportunities, and corporate responsibility. Technically, the site leverages Adobe Experience Manager CMS, modern JavaScript libraries, and integrates cookie consent and analytics tools to ensure compliance and user experience. Security posture is solid with HTTPS enforcement and cookie consent mechanisms, though some security headers and explicit security policies are absent. WHOIS data for the domain www.biogen.se is unavailable, likely due to the domain being a subdomain or managed under a parent domain, but the website content and branding strongly support legitimacy. Overall, the site demonstrates a mature digital presence with good privacy compliance and user trust indicators.

Biogen Slovenia is a regional branch of Biogen, a leading global biotechnology company specializing in innovative therapies for complex neurological, neuropsychiatric, immunological, and rare diseases. The website reflects a professional corporate presence with clear branding, comprehensive content about their mission, treatment areas, and corporate responsibility. Technically, the site is built on Adobe Experience Manager, hosted on AWS infrastructure, and employs modern web technologies including jQuery and Cookiebot for privacy compliance. Security posture is strong with HTTPS, secure cookies, and IP anonymization in analytics, though explicit security policies and incident response information are not published. Overall, the site is well-structured, GDPR compliant, and trustworthy, supporting Biogen's market position as a reputable pharmaceutical entity.

Biogen Portugal operates as a leading biotechnology company focused on innovative therapeutic solutions in neurology, neuropsychiatry, specialized immunology, and rare diseases. The website reflects a mature enterprise with a strong market position and a clear mission to improve global health through science. The digital infrastructure is built on Adobe Experience Manager with modern analytics and consent management tools, indicating a well-maintained and compliant online presence. Security posture is solid with HTTPS and cookie security best practices, though explicit security policies and incident response contacts are absent. Overall, the site is professional, trustworthy, and compliant with GDPR, supporting Biogen's reputation as a global healthcare leader.

Biogen Norway AS operates as a leading global biotechnology company specializing in neurology, neuropsychiatry, specialized immunology, and rare diseases. The company focuses on research, development, and innovation to improve patient lives and contribute to a healthier, sustainable world. The website targets healthcare professionals, patients, and stakeholders primarily in Norway, providing comprehensive information about therapies, corporate responsibility, and career opportunities. Technically, the website is built on Adobe Experience Manager CMS, leveraging modern JavaScript libraries such as jQuery and Adobe Helix RUM for performance monitoring. It employs Google Analytics and Google Tag Manager for analytics and tracking, alongside Cookiebot for cookie consent management. The site is mobile-optimized with good SEO and accessibility features, though some accessibility improvements are recommended. From a security perspective, the site enforces HTTPS and uses secure cookies with httpOnly flags. It implements a detailed cookie consent mechanism compliant with GDPR. However, it lacks explicit security headers and published security policies or incident response contacts, which are recommended for enhanced trust and compliance. Overall, the website presents a professional, trustworthy digital presence with strong privacy compliance and good technical implementation. The absence of WHOIS data is a limitation but does not detract significantly from the site's legitimacy given the quality of content and security posture.

Biogen Netherlands B.V. operates as a leading global biotechnology company specializing in the development and commercialization of innovative medicines for complex neurological and rare diseases. The website reflects a mature enterprise with a clear focus on scientific innovation and patient impact, targeting healthcare professionals and patients in the Netherlands. The company is part of the larger Biogen Inc. group, founded in 1978, with a strong market position in neurology and related therapeutic areas. The website content is professionally presented, with comprehensive information about disease areas, products, corporate responsibility, and career opportunities. Technically, the website is built on Adobe Experience Manager, leveraging modern web technologies including Cookiebot for consent management, Google Analytics for traffic analysis, and Adobe Helix RUM for performance monitoring. The site is mobile-optimized and demonstrates good SEO and accessibility practices, though some accessibility features could be enhanced. Hosting appears to be on AWS infrastructure, indicated by load balancer cookies. Security posture is solid with HTTPS enforced, HttpOnly cookies, and a cookie consent mechanism. However, explicit security policies and incident response contacts are not published, representing an area for improvement. No vulnerabilities or suspicious content were detected. Privacy compliance is strong, with GDPR-aligned cookie management and privacy policy. Overall, the website is trustworthy, professional, and well-aligned with the company's business objectives. Strategic recommendations include publishing formal security and incident response policies, enhancing accessibility, and maintaining vigilance on third-party scripts and tracking technologies.

Biogen Lithuania UAB is a subsidiary of the global biotechnology leader Biogen Inc., specializing in innovative treatments for neurological, neuropsychiatric, immunological, and rare diseases. The website presents a professional and consistent brand image, targeting healthcare professionals and patients in Lithuania. The company emphasizes scientific innovation and social responsibility in its mission. Technically, the site is built on Adobe Experience Manager CMS, uses modern JavaScript libraries like jQuery, and integrates Google Analytics and Cookiebot for analytics and privacy compliance. Security posture is solid with HTTPS and cookie security measures, though explicit security headers and incident response information are absent. The WHOIS data is unavailable, limiting domain trust verification, but the website's content and external references support legitimacy. Overall, the site is well-structured, GDPR compliant, and provides a good user experience.

Biogen Latvia SIA operates as a regional branch of the global biotechnology leader Biogen Inc., focusing on innovative therapies for neurological and rare diseases. The website reflects a professional corporate presence with clear branding, comprehensive content about their business focus, and a user-friendly interface optimized for mobile devices. The technical infrastructure leverages Adobe Experience Manager CMS, modern JavaScript libraries, and robust cookie consent management via Cookiebot, ensuring compliance with GDPR and enhancing user privacy. Security posture is strong with HTTPS enforced and secure cookie practices, though there is room for improvement in publishing explicit security policies and headers. Overall, the site demonstrates a mature digital presence aligned with industry standards and regulatory requirements.

Biogen Italia S.r.l. is a large, well-established biotechnology company operating in Italy as a subsidiary of the global Biogen Inc. The company specializes in innovative therapies for neurological, immunological, and rare diseases, with a strong focus on multiple sclerosis, spinal muscular atrophy, and Alzheimer's disease. The website reflects a professional corporate presence with clear branding, comprehensive content, and a user-friendly design targeting healthcare professionals and patients in Italy. Technically, the site is built on Adobe Experience Manager, uses modern analytics and consent management tools, and is hosted likely on AWS infrastructure. Security posture is strong with HTTPS, HttpOnly cookies, and GDPR-compliant cookie consent mechanisms, although no explicit security policy or incident response contacts are published. Overall, the site is trustworthy, compliant, and well-maintained, supporting Biogen's market position as a leader in biotechnology.

Biogen Hungary KFT operates as a local branch of the global biotechnology leader Biogen, focusing on developing therapies in neurology, neuropsychiatry, special immunology, and rare diseases. The website reflects a professional corporate presence with clear branding, comprehensive content about their business focus, and a strong emphasis on scientific innovation and patient care. The company targets healthcare professionals, patients, and stakeholders interested in advanced biotechnological solutions. Technically, the site is built on Adobe Experience Manager, uses modern JavaScript libraries like jQuery, and integrates Cookiebot for GDPR-compliant cookie management. Google Analytics and Google Tag Manager are employed for analytics and marketing purposes, with appropriate consent mechanisms in place. Security posture is strong with HTTPS enforced, security headers present, and no visible vulnerabilities or exposed sensitive data. However, explicit security policies and incident response information are not published, which could be improved. Overall, the site is well-structured, mobile-optimized, and trustworthy, supporting Biogen's market position as a leading biotechnology company.

Biogen Deutschland operates as a leading biotechnology company specializing in the research, development, and provision of innovative pharmaceutical therapies targeting complex and severe diseases, particularly in neurology and rare disorders. The website reflects a mature enterprise-level digital presence with comprehensive content tailored to patients, healthcare professionals, and partners. The company maintains a strong market position with a clear focus on innovation and patient care. Technically, the site leverages Adobe Experience Manager CMS, integrates modern analytics and consent management tools, and is hosted on AWS infrastructure, indicating a robust and scalable platform. Security posture is solid with HTTPS enforcement and cookie consent mechanisms, though there is room for improvement in explicit security policy disclosures and security headers. Overall, the site demonstrates high professionalism, compliance with GDPR, and trustworthy branding.

Biogen France is a large, internationally recognized biotechnology company specializing in innovative therapies for neurological and rare diseases. The website reflects a mature digital presence with comprehensive content about their therapeutic areas, corporate responsibility, and digital health initiatives. The technical infrastructure is built on Adobe Experience Manager with modern JavaScript libraries and analytics tools, ensuring a responsive and user-friendly experience. Security posture is strong with HTTPS, secure cookies, and a robust cookie consent mechanism, although some security headers and explicit security policies are absent. Privacy compliance is well addressed with GDPR-aligned policies and cookie management. Overall, the site demonstrates high professionalism and trustworthiness, supporting Biogen's market position as a leader in healthcare innovation.

Biogen is a leading global biotechnology company specializing in innovative treatments for complex and devastating diseases, particularly in neurology, neuropsychiatry, specialized immunology, and rare diseases. The Finnish website reflects the company's commitment to science-driven healthcare solutions and social responsibility. The site is professionally designed with clear navigation and consistent branding, targeting a general audience including patients, healthcare professionals, and potential employees. Technically, the website leverages Adobe Experience Manager as its CMS, integrates modern analytics and consent management tools such as Google Analytics and Cookiebot, and employs HTTPS with secure cookie practices. Security posture is solid with room for improvement in security headers and explicit security policies. Privacy compliance is strong, with comprehensive privacy and cookie policies and GDPR-aligned consent mechanisms. No critical vulnerabilities or suspicious content were detected, and the WHOIS data aligns well with the company's legitimacy and business claims.

Biogen Estonia OÜ operates as a local branch of the global biotechnology leader Biogen Inc., focusing on innovative treatments for complex neurological, neuropsychiatric, immunological, and rare diseases. The website is professionally designed, localized in Estonian, and provides comprehensive information about the company's mission, disease areas, and career opportunities. The digital infrastructure is built on Adobe Experience Manager, leveraging modern technologies such as jQuery, Google Tag Manager, and Cookiebot for consent management. Security posture is strong with HTTPS enforced and privacy-conscious analytics configuration. However, explicit security policies and incident response contacts are not published, representing an area for improvement. Overall, the website demonstrates a mature digital presence aligned with corporate standards and regulatory compliance.

Biogen (Denmark) A/S is a leading global biotechnology company focused on innovative research and development of treatments for serious and complex diseases, including neurological, neuropsychiatric, immunological, and rare diseases. The website reflects a professional corporate presence targeting healthcare professionals, patients, and potential employees. The company positions itself as a pioneer in healthcare innovation with a commitment to improving patient lives and societal health. Technically, the website is built on Adobe Experience Manager CMS, utilizing modern JavaScript libraries such as jQuery and Adobe Helix RUM for performance monitoring. It employs Google Analytics and Google Tag Manager for user analytics and tracking, complemented by a comprehensive cookie consent mechanism compliant with GDPR requirements. Security posture is strong with HTTPS enforced and use of secure cookies, though the absence of explicit security policies and incident response information is noted. The lack of WHOIS data for the domain slightly reduces trustworthiness but does not detract significantly from the overall legitimacy given the professional content and branding. Strategic recommendations include enhancing security headers, publishing security and incident response policies, and improving accessibility compliance.

Biogen.hr is the Croatian localized website of Biogen, a leading global biotechnology company specializing in innovative therapies for complex neurological and rare diseases. The website presents a professional and well-structured digital presence, leveraging Adobe Experience Manager CMS and hosted on AWS infrastructure. It features comprehensive cookie consent management via Cookiebot and integrates Google Analytics with IP anonymization, demonstrating a commitment to privacy compliance. While the site lacks explicit published security or incident response policies, it employs secure HTTPS protocols and best practices such as HttpOnly cookies. The content is targeted at a general audience in Croatia, focusing on healthcare professionals, patients, and stakeholders interested in Biogen's therapeutic areas and corporate responsibility. Overall, the website reflects a mature, trustworthy, and professional digital asset aligned with Biogen's global brand.

Biogen Belgium SA operates as a regional branch of the global biotechnology leader Biogen Inc., focusing on innovative therapies in neurology, neuropsychiatry, immunology, and rare diseases. The website targets healthcare professionals and patients in Belgium and Luxembourg, providing corporate information, therapeutic areas, and career opportunities. The digital infrastructure is built on Adobe Experience Manager with modern JavaScript libraries and integrates Google Analytics and Cookiebot for privacy compliance. Security posture is strong with HTTPS and secure cookies, though explicit security policies and incident response details are absent. The WHOIS data is restricted, common for .be domains, but the website's professional presentation and consistent branding support legitimacy. Overall, the site demonstrates a mature digital presence aligned with corporate standards.

Biogen is a globally recognized biotechnology company with a strong presence in Austria, focusing on pioneering scientific research and innovation in complex and severe diseases such as neurology, neuropsychiatry, immunology, and rare diseases. The website reflects a professional corporate identity with consistent branding and clear communication of their mission to improve health outcomes through science. Technically, the site is built on Adobe Experience Manager, uses modern JavaScript libraries like jQuery, and integrates Google Analytics and Cookiebot for analytics and privacy compliance. Security posture is solid with HTTPS enforced and HttpOnly cookies, though some security headers are not explicitly detected. Privacy compliance is well addressed with comprehensive cookie and privacy policies and a consent mechanism. The absence of WHOIS data is likely due to privacy protection, which is justified for this enterprise-level healthcare company. Overall, the website is trustworthy, well-maintained, and compliant with relevant regulations.

C

Chiesi Poland Sp. z o.o.

oddychajmy.pl

51

Oddychajmy.pl is a professionally developed healthcare portal operated by Chiesi Poland Sp. z o.o., focusing on providing comprehensive information, education, and support for patients suffering from Chronic Obstructive Pulmonary Disease (POChP) and their families. The website offers a variety of resources including expert articles, video tutorials, diagnostic guidance, and risk assessment tools, positioning itself as a niche but trusted source in the Polish healthcare information market. The content is well-structured, medically oriented, and targeted specifically at patients and caregivers, enhancing its relevance and utility. From a technical perspective, the website is built on the WordPress CMS platform, utilizing modern web technologies such as Bootstrap for responsive design, jQuery for interactivity, and integrates Google Tag Manager and Google Analytics for tracking and marketing purposes. The site demonstrates good mobile optimization, accessibility features, and SEO practices, though hosting provider details are not explicitly identified. Performance is moderate, with no critical technical issues detected. Security-wise, the site enforces HTTPS and implements a GDPR-compliant cookie consent mechanism with granular user controls, reflecting a strong privacy posture. However, there is a lack of explicit security headers and no publicly available security or incident response policies, which could be areas for improvement. No vulnerabilities or suspicious content were detected, and the WHOIS data aligns well with the business information, indicating legitimacy and trustworthiness. Overall, Oddychajmy.pl presents a low-risk profile with a solid foundation in content quality, privacy compliance, and business credibility. Strategic enhancements in security policy transparency and technical security headers would further strengthen its security posture and user trust.

C

Chiesi Poland Sp. z o.o.

totylkoastma.pl

49

The website 'To Tylko Astma' is a professionally developed healthcare education platform focused on asthma awareness and management in Poland. Sponsored by Chiesi Poland Sp. z o.o., a pharmaceutical company, it provides comprehensive educational content, multimedia resources, and reports targeting patients and caregivers across various age groups. The site leverages modern web technologies including WordPress, Bootstrap, and integrates analytics and user feedback tools such as Google Analytics, Hotjar, and Qualtrics to enhance user engagement and data-driven improvements. Security posture is strong with HTTPS enforced and no visible vulnerabilities, although security headers could be improved. Privacy and cookie policies are comprehensive and GDPR compliant, with clear contact information and transparent business details enhancing trustworthiness.

E

Everyday Health

everydayhealth.com

72

Everyday Health is a well-established digital health media company founded in 2002, providing trusted, medically reviewed health information, expert advice, and wellness resources to a broad audience. The website offers extensive content on health conditions, nutrition, fitness, product reviews, and tools such as symptom checkers and vaccine planners. It targets general consumers seeking reliable health information and wellness guidance. Technically, the site uses modern web technologies including React and Sitefinity CMS, with integrations for advertising and analytics through reputable providers like Google Tag Manager and Rubicon Project. The site is mobile-optimized and demonstrates good SEO and accessibility practices. Security-wise, the site enforces HTTPS, uses reCAPTCHA for bot protection, and implements cookie consent mechanisms, but lacks explicit security headers and a published security.txt file. The WHOIS data for the domain is unavailable, which slightly reduces domain registration transparency, but the site's content quality, editorial policies, and social media presence strongly support its legitimacy. Overall, the site is professional, trustworthy, and well-maintained, with minor areas for security and transparency improvement.

S

Sprida Reklambyrå

sprida.se

37

Sprida Reklambyrå is a Stockholm-based advertising agency specializing in healthcare and pharmaceutical marketing communications, serving primarily the Nordic market. Established since 1997, the company offers services including strategic communication, design, web development, and copywriting. The website reflects a professional small business with consistent branding and clear contact information. Technically, the site uses modern web standards and Google Tag Manager for analytics, hosted by LoopiaGroup2. Security posture is adequate with HTTPS enabled but lacks advanced security headers and DNSSEC. Privacy compliance is weak due to absence of privacy and cookie policies. Overall, the site is trustworthy and well-maintained but could improve compliance and security practices.

M

MedAdvisor International Pty Limited

medsinfo.com.au

57

medsinfo.com.au is a specialized healthcare information website providing up-to-date Consumer Medicine Information (CMI) and Product Information (PI) for medicines approved in Australia. Sponsored and funded by MedAdvisor International Pty Limited, the site targets both consumers and health professionals, supporting the National Strategy for the Quality Use of Medicines. The business model focuses on free access to authoritative medicine information without advertising, enhancing trust and user experience. Technically, the site is built on Angular framework with modern web technologies and uses Cloudflare DNS services. Google Tag Manager is employed for analytics, although no cookie consent mechanism is present. Security posture is moderate with HTTPS enforced but lacking explicit security headers and published security policies. WHOIS data indicates a consistent and legitimate domain registration with no privacy protection, aligning with the business purpose. Overall, the website is professional, trustworthy, and content-rich, but could improve privacy compliance and security best practices.

U

UCB Pharma Sp. z o.o.

ucb.pl

64

UCB Pharma Sp. z o.o. is a pharmaceutical company operating in Poland, focused on providing prescription medicines and patient support for serious diseases. The company is part of the global UCB group and targets patients, healthcare professionals, and pharmacies. The website is professionally designed using Drupal CMS, with good mobile optimization and accessibility features. It employs modern analytics and cookie consent tools to ensure compliance and user tracking moderation. Security posture is strong with HTTPS, security headers, and no visible vulnerabilities, although explicit security policies and incident response information are not published. Overall, the website reflects a trustworthy and credible business presence in the healthcare sector.

Teva Poland operates as a pharmaceutical company specializing in generic and specialty medicines, positioning itself as a global leader in generic drug manufacturing. The website is professionally designed, targeting patients, healthcare professionals, and pharmacies in Poland. It offers comprehensive information about products, corporate responsibility, and patient support initiatives. The digital infrastructure leverages modern JavaScript libraries and analytics tools, ensuring good performance and user experience across devices. Security posture is solid with HTTPS and cookie consent mechanisms, though some security headers and explicit policies could be enhanced. The absence of WHOIS data is due to registry privacy policies, which is common and justified for such enterprises. Overall, the website reflects a mature, trustworthy business presence with moderate tracking and compliance adherence.

S

Servier

servier.pl

55

Servier Polska operates as a pharmaceutical company in Poland, providing healthcare products and services primarily targeting healthcare professionals and patients. The website reflects a corporate presence with basic content and design elements, including the use of Font Awesome Pro icons. The domain is well-established since 1998 and secured with DNSSEC, indicating a legitimate and trustworthy entity. However, the website lacks visible privacy, cookie, and terms of service policies, as well as explicit contact information, which limits transparency and user trust. Technically, the site uses modern iconography but lacks evidence of advanced frameworks or analytics tools. Security posture is moderate with HTTPS and DNSSEC enabled but missing key security headers and policies. Overall, the site is safe for general audiences with no adult or explicit content detected.

S

Sanofi Pasteur

sanofipasteur.pl

51

The domain sanofipasteur.pl currently hosts a parked page with no active business content, serving as a placeholder rather than an operational website. Sanofi Pasteur is a globally recognized healthcare company specializing in vaccines, but this domain does not reflect active digital presence or business operations. The technical infrastructure is minimal, relying on an iframe to a parking service and loading consent management scripts without actual consent banners or policies. Security posture is weak due to lack of DNSSEC, security headers, and HTTPS details. The domain's recent registration date is inconsistent with the established brand history, suggesting this is a newly acquired or reserved domain rather than an official site. Overall, the website lacks essential compliance, contact, and trust indicators.

R

Roche Polska

roche.pl

63

Roche Polska is a leading healthcare company in Poland, providing innovative solutions in health protection. The website reflects a professional and consistent brand image aligned with Roche's global identity. The target audience includes healthcare professionals and patients within Poland. Technically, the site is built using modern frameworks such as Gatsby and React, offering good mobile optimization and accessibility. However, there is a lack of visible privacy and cookie policies, security headers, and explicit contact information, which are areas for improvement. The security posture is moderate with no detected blocking or WAF interference, but the absence of security best practices lowers the overall security score. Overall, the website is credible and trustworthy but could enhance compliance and security transparency.

N

Novo Nordisk

novonordisk.pl

73

Novo Nordisk Polska is the Polish branch of Novo Nordisk, a leading global healthcare company specializing in innovative therapies for chronic diseases such as diabetes, obesity, haemophilia, and menopause. The website serves Polish patients, healthcare professionals, and job seekers, providing comprehensive information about the company's scientific approach, heritage, and business activities. The company holds a strong market position with over 100 years of history and operates as an enterprise-level pharmaceutical business.

N

Novartis Poland

novartis.pl

70

Novartis Poland operates as a regional branch of the global healthcare giant Novartis AG, providing innovative pharmaceutical solutions including oncology, rare disease treatments, and advanced therapies such as gene and cell therapy. The website reflects a mature digital presence with professional design, localized content in Polish, and integration of modern web technologies and analytics tools. The security posture is strong with HTTPS enforcement and cookie consent mechanisms, though some security headers and explicit incident response information are absent. WHOIS data is unavailable for the queried domain, which may be due to privacy protection or query limitations, but the website's branding and social media presence strongly support its legitimacy. Overall, the site demonstrates a high level of professionalism and compliance with privacy regulations.

E

Eli Lilly and Company

lilly.pl

74

Eli Lilly and Company operates the localized Polish website www.lilly.com/pl to provide information about its pharmaceutical products, therapeutic areas, and corporate responsibility. The site targets healthcare professionals and patients in Poland, offering detailed content about the company's values, products, and safety information. The website demonstrates a mature digital infrastructure using modern JavaScript frameworks and includes comprehensive privacy and cookie consent mechanisms, reflecting compliance with GDPR and local regulations. Security posture is good with HTTPS and consent management, though explicit security policies and incident response information are not publicly detailed. Overall, the site is professional, trustworthy, and well-maintained, supporting Eli Lilly's market position as a leading pharmaceutical enterprise.

C

Chiesi Poland

chiesi.pl

70

Chiesi Poland operates as a pharmaceutical company specializing in therapeutic areas such as respiratory health, neonatology, transplantology, and pediatrics. The company is part of the international Chiesi Group and demonstrates a commitment to corporate social responsibility, sustainability, and ethical business practices, evidenced by its B Corp certification. The website serves healthcare professionals, patients, and partners in Poland, providing product information, corporate news, and resources. Technically, the website employs a range of JavaScript libraries including jQuery, bxSlider, and Colorbox, alongside Google Maps API and OneTrust for cookie consent management. Accessibility is enhanced through the integration of AccessiWay. The site is mobile optimized and presents a professional design with clear navigation, although SEO metadata and structured data are minimal. From a security perspective, the site enforces HTTPS and uses a cookie consent mechanism, but lacks visible security headers and does not publish a security or incident response policy. No vulnerabilities or exposed sensitive data were detected in the HTML content. The absence of WHOIS data limits domain trust verification, but the professional content and corporate branding support legitimacy. Overall, the website is well-constructed and compliant with privacy regulations, but could improve transparency around security policies and domain registration details to enhance trust and security posture.

B

Boehringer Ingelheim

boehringer-ingelheim.pl

62

Boehringer Ingelheim is a leading pharmaceutical company focused on innovation and improving health for humans and animals. The website is professionally designed, multilingual, and provides comprehensive information about the company’s mission, products, and sustainability efforts. Technically, the site uses modern web standards, structured data, and is mobile optimized, reflecting a mature digital presence. Security posture is strong with HTTPS and no obvious vulnerabilities, though explicit security policies and cookie consent mechanisms could be improved. The WHOIS data is unavailable, which is unusual for a company of this size, but the website content and external references strongly support legitimacy. Overall, the site represents a trustworthy and professional corporate presence.

Biogen Poland Sp. z o.o. operates as a local subsidiary of the global biotechnology leader Biogen, focusing on innovative therapies in neurology, neuropsychiatry, immunology, and rare diseases. The website targets Polish users with comprehensive information about the company, its therapeutic areas, career opportunities, and corporate responsibility. The digital infrastructure is built on Adobe Experience Manager, leveraging modern web technologies including jQuery, Cookiebot for consent management, and Google Analytics for user insights. The site is well-structured, mobile-optimized, and compliant with GDPR regulations, featuring clear cookie and privacy policies. Security posture is strong with HTTPS enforced and secure cookie practices, though some security headers could be improved. WHOIS data is unavailable due to registry restrictions, but the site’s professional presentation and linkage to Biogen’s global domains support its legitimacy.

A

AstraZeneca

astrazeneca.pl

62

AstraZeneca Poland's website serves as a comprehensive corporate portal providing information about the company's pharmaceutical products, clinical trials, innovations, and sustainability initiatives targeted at Polish audiences including healthcare professionals and patients. The site reflects AstraZeneca's position as a leading global biopharmaceutical company with a strong focus on innovation and patient care. Technically, the website is built on Adobe Experience Manager CMS, hosted on AWS infrastructure, and employs modern analytics and tag management tools such as Adobe Analytics and Tealium. The site is mobile-optimized, accessible, and SEO-friendly, with a consistent and professional design. Security posture is strong with HTTPS enforced and cookie consent mechanisms in place, though explicit security headers and incident response disclosures could be improved. The absence of WHOIS data for the domain is notable but does not detract from the site's legitimacy given its corporate branding and linkage to official AstraZeneca domains. Overall, the website demonstrates a mature digital presence aligned with enterprise standards.

A

Angelini Pharma Polska Sp. z o.o.

angelini.pl

66

Angelini Pharma Polska Sp. z o.o. is a Polish subsidiary of the Italian Angelini S.p.a., specializing in pharmaceutical production and distribution with a focus on therapeutic areas such as depression, pain, cold symptoms, and rare diseases. The company holds a strong market position in Poland, supported by a professional website that provides comprehensive information about its products, research, corporate responsibility, and global presence. The website is well-structured, mobile-optimized, and integrates modern JavaScript libraries and analytics tools, reflecting a mature digital infrastructure. Security posture is good with HTTPS enforced and no evident vulnerabilities, though some security headers could be improved. Privacy and cookie policies are present and GDPR compliant, enhancing user trust. The absence of WHOIS data is a minor concern but does not detract significantly from the overall legitimacy given the professional presentation and known parent company affiliation.

A

Amgen Polska Sp. z o.o.

amgen.pl

70

Amgen Polska Sp. z o.o. operates as a subsidiary of the global biotechnology leader Amgen Inc., focusing on innovative human therapeutics within the healthcare sector. The website serves healthcare professionals, patients, and partners by providing comprehensive information about products, corporate affairs, and patient support programs. The company holds a strong market position in Poland, supported by its global reputation and local presence. The business model centers on biopharmaceutical development and patient engagement, reflecting a mature and established enterprise founded in 1980. Technically, the website employs modern web technologies including JavaScript frameworks, Bootstrap for responsive design, and Cookiebot for consent management, indicating a good level of digital maturity. The site is mobile-optimized and incorporates SEO best practices, although some accessibility features could be enhanced. Hosting details are not explicit, but the infrastructure supports moderate performance and reliable user experience. From a security perspective, the site enforces HTTPS with a solid SSL configuration and includes a Content Security Policy header. Cookie consent mechanisms comply with GDPR, and no critical vulnerabilities or exposed sensitive data were detected. However, additional security headers and a formal security policy could further strengthen the posture. The WHOIS data confirms the legitimacy and consistency of the domain registration with the corporate identity. Overall, the website presents a low-risk profile with strong business credibility and compliance adherence. Strategic recommendations include enhancing security headers, publishing incident response contacts, and improving accessibility to elevate the user experience and security maturity further.

A

Almirall

almirall.pl

70

Almirall is a healthcare company focused on improving patient outcomes through pharmaceutical products and therapies, with a dedicated presence in Poland. The website reflects a professional and well-structured digital presence, leveraging modern technologies such as Liferay CMS, Google Tag Manager, Google Analytics, and accessibility tools to ensure compliance and user experience. Privacy and cookie consent mechanisms are robust, indicating a commitment to GDPR compliance. However, the absence of WHOIS data limits the ability to fully verify domain registration legitimacy. Security posture is strong with HTTPS and security headers, but explicit security policies and incident response contacts are not publicly available, representing an area for improvement. Overall, the website is trustworthy, well-maintained, and aligned with industry standards.

AbbVie is a global bio-pharmaceutical company with a strong presence in Poland, focusing on advanced drug research, development, and patient therapies. The website reflects a professional and consistent brand image, targeting patients, healthcare professionals, and researchers. Technically, the site uses Adobe Experience Manager CMS and integrates Brightcove for video content, alongside multiple third-party analytics and advertising services. Security posture is adequate with HTTPS enabled but lacks visible security headers and explicit privacy or cookie policies. No contact or incident response information is readily available, which could impact user trust and compliance. Overall, the site is well-structured and content-rich, but improvements in privacy compliance and security transparency are recommended.

AbbVie is a global bio-pharmaceutical company with a strong presence in Poland, focusing on research, development, and delivery of innovative therapies that improve patients' lives. The website reflects a professional and consistent brand image, targeting patients, healthcare professionals, and researchers. The technical infrastructure leverages Adobe Experience Manager CMS, Brightcove video technology, and multiple analytics and advertising platforms, indicating a mature digital presence. Security posture is adequate with HTTPS enabled but lacks visible security headers and explicit security policies. Privacy compliance is weak due to missing privacy and cookie policies and consent mechanisms. Overall, the website is trustworthy and professional but could improve in privacy and security transparency.

A

Alector Therapeutics

alector.com

76

Alector Therapeutics is a biopharmaceutical company specializing in developing therapies for neurodegenerative diseases. Founded in 2008, the company positions itself as an innovative player in the healthcare sector, focusing on advancing treatments that address critical unmet needs in neurodegeneration. Their website targets patients, investors, and the scientific community, providing detailed information about their scientific approach, pipeline, and patient resources. The company maintains a professional online presence with comprehensive privacy and cookie policies, reflecting strong compliance with GDPR and data protection standards. Technically, the website is built on WordPress and leverages modern web technologies including jQuery, Bootstrap, and Flickity for UI components, alongside Google Tag Manager for analytics and OneTrust for cookie consent management. The site is mobile-optimized and demonstrates good SEO and accessibility practices, although some accessibility features could be enhanced. Hosting and DNS are managed via DomainControl, with no DNSSEC enabled, which is a recommended improvement. From a security perspective, the site enforces HTTPS and uses cookie consent mechanisms, but lacks some advanced security headers such as Content-Security-Policy and X-Content-Type-Options. No vulnerabilities or exposed sensitive data were detected in the HTML content. The WHOIS data confirms domain legitimacy with a long registration period and appropriate domain status flags. Overall, the security posture is solid but could benefit from additional hardening. The overall risk assessment is low, with no signs of malicious activity or suspicious content. Strategic recommendations include enabling DNSSEC, implementing additional security headers, and publishing a vulnerability disclosure policy to enhance transparency and trust. The website's design, content quality, and compliance measures position Alector as a credible and trustworthy healthcare company online.

T

Therini Bio

therinibio.com

58

Therini Bio is a small biotechnology company specializing in the development of novel therapeutics targeting neuroinflammation and vascular dysfunction, with a clinical-stage pipeline focused on diseases such as Alzheimer's and diabetic macular edema. The company positions itself as a pioneer in fibrin-targeting immunotherapies, supported by a syndicate of reputable life sciences investors. The website reflects a professional and consistent brand image, targeting healthcare professionals, researchers, investors, and patients. Technically, the site is built on WordPress using the Divi theme, with good SEO and mobile optimization, though some accessibility features could be improved. Security posture is solid with HTTPS and cookie consent mechanisms, but lacks some security headers and explicit incident response information. The absence of WHOIS data is a notable anomaly that slightly reduces trust but does not outweigh the professional presentation and content quality. Overall, the site demonstrates a mature digital presence appropriate for a clinical-stage biotech firm.

T

Tallac Therapeutics, Inc

tallactherapeutics.com

47

Tallac Therapeutics, Inc is a small, privately held biopharmaceutical company specializing in next generation antibody drug conjugates (ADCs) for cancer immunotherapy. Their innovative pipeline includes Toll-like Receptor Agonist Antibody Conjugates (TRAAC) designed to activate immune responses within tumors. The company targets healthcare professionals, researchers, and investors interested in immuno-oncology. The website is built on WordPress with Elementor, showing moderate technical maturity and good mobile optimization. Security posture is adequate with HTTPS but lacks advanced security headers and public security policies. WHOIS data is unavailable, which raises some legitimacy concerns, though the website content and external LinkedIn presence support the company's credibility. Contact information is clearly provided, but privacy and cookie policies are missing, impacting compliance. Overall, the site is professional and trustworthy but could improve transparency and security practices.

R

Ray Therapeutics, Inc.

raytherapeutics.com

64

Ray Therapeutics, Inc. is a specialized biotechnology company focused on developing optogenetic therapies to restore vision for patients suffering from degenerative retinal diseases. Their innovative approach involves reprogramming surviving retinal neurons to sense light and transmit visual signals to the brain, positioning them as an emerging player in the healthcare and biopharmaceutical sector. The company maintains a professional online presence with clear descriptions of their science, pipeline, leadership, and patient focus. Technically, the website is built on WordPress using Elementor and the Genesis Block Theme, with moderate performance and good mobile optimization. Security posture is adequate with HTTPS enforced and domain registration protections, but could be improved by enabling DNSSEC and adding security headers. Privacy compliance is strong, featuring comprehensive privacy and cookie policies with consent mechanisms. No direct contact emails or phone numbers are publicly listed, relying on a contact form instead. Overall, the website reflects a legitimate, professional biotech startup with room for technical and security enhancements.

P

Photys Therapeutics

photys.com

60

Photys Therapeutics is a biotechnology company specializing in the development of proprietary chimeric small molecules aimed at precise control of protein post-translational modifications. The company positions itself as an innovator in the healthcare sector, targeting drug discovery and development with a platform-based approach. The website is professionally designed using the Wix platform, indicating a moderate level of digital maturity with basic SEO and mobile optimization. However, the absence of WHOIS data raises concerns about domain legitimacy and transparency. Security posture is adequate with HTTPS enabled but lacks advanced security headers and privacy compliance documentation. Overall, the site presents a professional front but would benefit from enhanced security practices and clearer business contact information to improve trust and compliance.

P

Paq

paqtx.com

57

Paq Therapeutics is a biopharmaceutical company focused on developing KRAS degraders to treat deadly cancers lacking effective therapies. The website presents a professional and well-structured digital presence built on WordPress, leveraging modern frameworks such as Bootstrap and Yoast SEO for optimization. However, the absence of WHOIS registration data raises concerns about domain legitimacy and ownership transparency. Security posture is moderate with HTTPS enabled but lacking essential security headers and privacy compliance documentation. Contact information and incident response policies are not provided, limiting trust and compliance assurance. Overall, the site is functional and content-rich but requires improvements in security, compliance, and transparency to enhance credibility and reduce risk.

M

Mozart Therapeutics

mozart-tx.com

57

Mozart Therapeutics is a clinical-stage biopharmaceutical company specializing in the development of novel CD8 Treg modulators aimed at treating autoimmune and inflammatory diseases. Their website presents a professional and scientifically focused image, highlighting their pipeline and scientific approach. The company targets healthcare professionals, investors, and patients interested in innovative autoimmune therapies. The business model centers on advancing proprietary biologics to restore immune homeostasis. Technically, the website employs a simple tech stack including jQuery 1.9.0 and Google Analytics with IP anonymization. The site is well-structured, mobile-optimized, and accessible, though it lacks modern frameworks or CMS identification. Performance is moderate, and SEO practices are adequate. However, the use of an outdated JavaScript library and absence of security headers suggest areas for technical improvement. From a security perspective, the site lacks visible security headers and formal privacy or cookie policies, which impacts privacy compliance negatively. No contact information or incident response channels are provided, limiting transparency and trust. The WHOIS data is notably absent, raising concerns about domain registration legitimacy despite the active and professional website presence. This discrepancy reduces overall trustworthiness. Overall, the website is functional and professional but requires improvements in privacy compliance, security posture, and domain registration transparency to enhance trust and security. Strategic recommendations include implementing security headers, publishing privacy and cookie policies with consent mechanisms, providing clear contact and incident response information, updating technical libraries, and clarifying domain registration details.

L

LifeMine Therapeutics

lifeminetx.com

61

LifeMine Therapeutics is a clinical-stage biopharmaceutical company specializing in innovative drug discovery leveraging evolutionary insights from fungi. Their proprietary Top-Down Drug DiscoveryTM platform aims to develop next-generation precision medicines, with a lead clinical program LIFE-001 targeting immune-mediated diseases and organ transplant rejection. The company is positioned as a medium-sized biotech innovator with a global presence including offices in the United States and Switzerland. The website reflects a professional and modern digital presence built on WordPress with advanced SEO and multimedia content, targeting patients, healthcare professionals, and investors. Security posture is solid with HTTPS and domain protections, though some enhancements in security headers and privacy compliance are recommended. Overall, the site is trustworthy, well-branded, and content-rich, supporting LifeMine's market position as a cutting-edge biotech company.

I

InduPro, Inc.

induprolabs.com

57

InduPro, Inc. is a biotechnology company specializing in proximity-based therapeutics, focusing on manipulating protein interactions on cell surfaces to develop innovative treatments for diseases. The company targets pharmaceutical and biotech sectors, leveraging proprietary platforms to facilitate new biology and drug discovery. Their website presents a professional image with clear scientific and team information, positioning them as an innovative player in the healthcare industry. Technically, the website is built on WordPress with modern plugins and libraries such as Yoast SEO, FullPage.js, and D3.js, indicating a moderate to good level of digital maturity. The site is mobile-optimized and SEO-friendly, though some accessibility features could be improved. Security-wise, the site uses HTTPS and modern JavaScript libraries but lacks visible security headers and formal privacy or cookie policies, which are areas for improvement. The security posture is generally good with no visible vulnerabilities or exposed sensitive data, but the absence of WHOIS data for the domain raises concerns about domain registration legitimacy. Contact information is clearly provided, enhancing business credibility. Overall, the site is trustworthy and professional but would benefit from enhanced privacy compliance and domain registration transparency.

H

HotSpot Therapeutics, Inc.

hotspotthera.com

58

HotSpot Therapeutics, Inc. is a biotechnology company specializing in pioneering allosteric drug discovery through its proprietary Smart Allostery™ platform. The company focuses on developing novel medicines targeting natural hotspots on proteins to treat cancer and autoimmune diseases. The website presents a professional and well-structured digital presence, targeting industry professionals, investors, and patients interested in innovative therapeutics. The business model centers on drug discovery and pipeline development, positioning HotSpot as an innovator in the healthcare sector.